HIG BioVentures

We have detected that you do not have scripting allowed or the latest version of Macromedia Flash Player.

In order to display the content, please allow scripting or download and install the latest version now.

It will only take a moment. Click here to download Flash Player


	H.I.G. BioVentures invests in a broad range of life science opportunities across sectors and stages. Our seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. We invest in companies developing novel products for significant unmet medical needs. more >


	Investment Spotlight H.I.G. BioVentures invests in Clarus Therapeutics, a Northbrook, IL specialty pharmaceutical company developing the first oral testosterone replacement for the treatment of male hypogonadism.